Home › Bleeding › Georgia › Atlanta
Bleeding clinical trials in Atlanta, GA
6 studies for Bleeding are looking for participants at sites in and around Atlanta (within about 30 miles). Open a study to see who can join and how to contact the study team.
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
RecruitingPhase 2
- Grady Health System, Atlanta
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
RecruitingPhase 3
- Atlanta Clinical Research Centers, Atlanta
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
RecruitingPhase 3
- Emory University, Atlanta
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
RecruitingPhase 3
- Emory University, Atlanta
Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG
RecruitingPhase 3
- Emory University, Atlanta
- Piedmont Healthcare Inc., Atlanta
Eptacog Beta in Glanzmann's (HeT_LFB-Strength-Study_FID531)
RecruitingPhase 2
- Arthur M. Blank Hospital | Children's Healthcare of Atlanta, Atlanta
About Bleeding
Bleeding is the loss of blood, inside or outside the body. A hemorrhage is severe bleeding. Learn about the causes of bleeding and how to treat it.
More about Bleeding on MedlinePlus
Bleeding trials in other cities
- Boston, MA10 studies
- New York City, NY8 studies
- Houston, TX7 studies
- Cleveland, OH6 studies
- Chicago, IL6 studies
- Philadelphia, PA5 studies
- Seattle, WA5 studies
- Durham, NC5 studies
- St. Louis, MO5 studies
- Indianapolis, IN4 studies
- Cedar Rapids, IA4 studies
- San Diego, CA4 studies
Other studies in Atlanta
- Cancer (all types)50 studies
- Non-Small Cell Lung Cancer46 studies
- Breast Cancer41 studies
- Multiple Myeloma41 studies
- Prostate Cancer32 studies
- Lung Cancer29 studies
- Acute Myeloid Leukemia29 studies
- Colorectal Cancer29 studies
- Ovarian Cancer28 studies
- Metastatic Cancer27 studies
- Heart Failure25 studies
- Obesity25 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.